Goldman Sachs Downgrades Tenet Healthcare: What You Need to Know
Goldman Sachs Downgrades Tenet Healthcare, Upgrades Lifestance Health Group Goldman Sachs analyst Jamie Perse recently downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. This decision was made amid rising policy uncertainty in the healthcare sector, with a wide range of potential outcomes. The analyst explained in a…